New FDA draft guidance outlines reduced reliance on primates for monoclonal antibody toxicity testing, aiming to lower costs and accelerate drug development.
Dr. Nageswara Rao Koneti's KONAR-MF Occluder receives US patent, offering a cost-effective solution for various heart defects. With global recognition, the device aims for FDA approval